Nurix Therapeutics (NRIX) Stock: Buy, Sell, or Hold?
NRIX - Nurix Therapeutics, Inc. Common stock
$23.34
-0.37 (-1.56%)
▼
5d:
-1.31%
30d:
-10.37%
90d:
-2.63%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 08, 2026
5d
Get Alerted When NRIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRIX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NRIX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NRIX is currently trading at $23.34, which is considered oversold relative to its 30-day fair value range of $24.28 to $26.42.
Technical Outlook: Technically, NRIX is in a strong uptrend. Immediate support is located at $22.41, while resistance sits at $25.96.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.93 (+45.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRIX is in a strong uptrend. Immediate support is located at $22.41, while resistance sits at $25.96.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.93 (+45.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$24.28 -
$26.42
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.4% below Wall St target ($33.93)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$24.28 -
$26.42
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$22.41
Resistance Level
$25.96
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-21.91
Wall Street Target
$33.93
(+45.4%)
Revenue Growth (YoY)
-79.5%
Share & Embed Analysis
Last updated: October 02, 2026 12:48 AM ET
Data refreshes hourly during market hours. Next update: 1:48 AM
Data refreshes hourly during market hours. Next update: 1:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 68 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 63 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 60 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 68 BUY |
